← Open Payments lookup

KAITLIN JASMON: Open Payments

NPI 1760805949 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,206 in 86 payments from 14 companies in 2025. Trend: 2023 $489 · 2024 $1,406 · 2025 $2,206

Food & beverage: $2,146Education: $60
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$375
GENZYME CORPORATION13$338
GlaxoSmithKline, LLC.12$269
Regeneron Healthcare Solutions, Inc.15$265
Boston Scientific Corporation1$257
Grifols USA, LLC10$197
Takeda Pharmaceuticals U.S.A., Inc.6$140
Verona Pharma, Inc.6$99
Insmed, Inc.4$72
SANOFI-AVENTIS U.S. LLC1$60

Products named: DUPIXENT, WATCHMAN FLX, NUCALA, Prolastin-C Liquid, BREZTRI, GLASSIA, FASENRA, Ohtuvayre.

Industry payments across IN — which companies pay providers there.